Abstract: Iodine-125 is produced by neutron irradiation of .sup.124 Xe gas to form .sup.125 Xe and permitting decay of .sup.125 Xe to form .sup.125 I. Irradiation of the xenon-124 is effected in a first chamber within an enclosure and decay is effected in a second chamber within the enclosure and free from neutron flux. The apparatus is submersible in a nuclear reactor pool so as to absorb any radiation escaping the apparatus during the process. Xenon can be caused to move between the chambers remotely, underwater. The second chamber is removable from said enclosure and is transported to a suitable location to recover the .sup.125 I from its interior. Such recovery is effected by admitting an aqueous wash solution into the second chamber, whereupon it is heated, causing water from the wash solution to reflux and cleanse the interior surfaces of the second chamber, thus creating an aqueous solution of .sup.125 I, which then is caused to drain into a suitable container.

Abstract: The process of invention provides a simplified conversion of sulfur dioxide gas into hydrogen sulfide gas. First, sulfur dioxide gas is absorbed into an aqueous sulfide solution to form sulfite and bisulfide ions. Second, additional sulfur dioxide gas is absorbed into the aqueous solution to form hydrogen sulfide. Third, another portion of the sulfur dioxide is absorbed and reacts in the aqueous solution to form bisulfite. Most advantageously, the bisulfite is decomposed into sulfur dioxide and sulfite. The sulfite is then reduced to sulfide and returned for use in the absorption process. The hydrogen sulfide may then be reacted with SO.sub.2 via the Claus reaction to form elemental sulfur.

Abstract: A composite high Tc superconductor film is applied to a substrate, said film as applied having a thickness of at least 5000 Angstrom and an outer surface having an average roughness not exceeding 250 Angstrom.

Abstract: Methods for detecting hematologic and colorectal malignancies are provided comprising: (a) collecting a sample suspected of containing cancer cells; (b) analyzing the sample for telomerase activity; (c) correlating the presence of telomerase activity with the presence of cancer cells. A method for staging leukemia is also provided comprising analyzing a blood or bone marrow sample for telomerase activity, correlating the activity with a standard level of telomerase activity, and correlating a low telomerase activity with early stage leukemia.

Abstract: An increased level of translation of a selected mRNA molecule is effected by coupling specific nucleotide sequences at the 5'- and 3'-ends of a nucleic acid molecule transcribable to or which itself is the mRNA molecule. The nucleotide sequence at the 5'-end is effective to increase the rate of translation initiation of the mRNA molecule in a cell while the nucleotide sequence at the 3'-end is effective to increase the period of translation of the mRNA molecule in a cell.

Abstract: An increased level of translation of a selected mRNA molecule is effected by coupling specific nucleotide sequences at the 5'- and 3' -ends of a nucleic acid molecule transcribable to or which itself is the mRNA molecule. The nucleotide sequence at the 5'-end is effective to increase the rate of translation initiation of the mRNA molecule in a cell while the nucleotide sequence at the 3'-end is effective to increase the period of translation of the mRNA molecule in a cell. The nucleotide sequence of the 3'-end is provided by a 3'-untranslated region (3'-UTR) of a gene, particularly that of .beta.-prolactin, or an effective fragment thereof. A polyadenylation sequence preferably is provided at the 3'-end of the 3'-UTR sequence. The 3'-UTR sequence provides mRNA stabilization independent of the poly A tail.

Abstract: A method for decreasing metalloproteinase activity in a patient that comprises the step of administering to said patient a therapeutic composition comprising the cytokine oncostatin-M, or a biologically active fragment, mutant, analog or fusion construct thereof. Also, a method for increasing TIMP activity in a patient that comprises the step of administering to said patient a therapeutic composition comprising the cytokine oncostatin-M, or a biologically active fragment, mutant, analog or fusion construct thereof. In addition a method for inhibiting or treating progression of a tumor in a patient that comprises the step of administering to said patient a therapeutic composition comprising oncostatin-M, or a biologically active fragment, mutant, analog, or fusion construct thereof, said method being effective to inhibit invasion by a tumor cell through an extracellular space, extracellular matrix, basement membrane, interstitial tissue or connective tissue.

Abstract: Methods for coating a prosthetic surface with anti-thrombogenic, or anti-coagulant, proteins are disclosed. The methods involve contacting a surface of a prosthetic material with a composition containing multimers of fibrin degradation products. These multimers, preferably D-dimers, have cross-linked D-domains. The methods of the invention are useful for providing an anti-thrombogenic coating on prosthetic implants which are exposed to a patient's blood after implantation, for example vascular grafts and artificial heart valves.

Abstract: A particulate carrier for an agent comprising a solid core of a polysaccharide and a proteinaceous material and an organometallic polymer bonded to the core is provided. The agent has a biological activity, such as immunogenicity, and may comprise the proteinaceous material or be a separate component of the core. Polysaccharide cores include dextran, starch, cellulose and derivatives thereof and the organometallic polymer includes silicones including substituted silicones. The particulate carriers are useful for delivering agents to the immune system of a subject by mucosal or parenteral administration to produce immune responses, including antibody responses.

Abstract: A capacitor structure for a memory element of an integrated circuit is provided. The capacitor is formed within a via hole defined through a first dielectric layer, and comprises a bottom electrode defined by an underlying conductive layer, and a capacitor dielectric filling the via with a dielectric barrier layer lining the via and separating the capacitor dielectric from the first dielectric layer. The capacitor dielectric is characterized by a material with high dielectric strength, preferably a ferroelectric material. An overlying conductive layer defines a top electrode contacting the capacitor dielectric. The barrier layer may comprise dielectric sidewall spacer formed within the via, or alternatively may comprise a region of mixed composition formed by interdiffusion of the first dielectric layer and the capacitor dielectric. The resulting capacitor structure is simple and compact, and may be fabricated with known CMOS, Bipolar or Bipolar-CMOS processes for submicron VLSI and ULSI integrated circuit.

Abstract: A method is provided for forming a capacitor structure for a memory element of an integrated circuit. The method comprises providing a first conductive electrode, forming a layer of a first dielectric material thereon, opening a via hole through the dielectric layer, providing within the via opening a capacitor dielectric having a higher dielectric strength than the first dielectric, the capacitor dielectric contacting the first electrode, planarizing the resulting structure and then forming a second conductive electrode thereon. Preferably, when the second dielectric comprises a ferroelectric dielectric material, sidewalls of the via opening are lined with a dielectric barrier layer to provide diffusion barrier between the ferroelectric and first dielectric layer. Advantageously, planarization is accomplished by chemical mechanical polishing to provide fully planar topography.

Abstract: Surfaces of polymeric materials are coated with a layer of thermally denatured fibrinogen. The fibrinogen may be treated with thrombin to produce fibrin, and additional fibrinogen and factor XIII added to produce a cross-linked fibrin coating. The resulting coated surface is stable, anti-thrombotic and resistant to platelet adhesion. Polymeric materials coated in this way are useful in constructing vascular grafts and prosthetic devices, and provide test systems useful in the study of thrombogenesis.

Abstract: A method for facilitating the transfer of nucleic acids into cells comprising preparing a mixed lipid dispersion of a cationic lipid with a co-lipid in a suitable carrier solvent. The lipid has a structure which includes a lipophilic group derived from cholesterol, a linker bond, a spacer arm including from about 1 to about 20 carbon atoms in a branched or unbranched linear alkyl chain, and a cationic amino group selected from the group consisting of primary, secondary, tertiary and quaternary amino groups. The method further comprises adding the nucleic acids to the dispersion to form a complex. The cells are then treated with the complex. There is also disclosed a novel cationic amphiphile useful for this purpose.

Abstract: Surfaces of polymeric materials are coated with a layer of thermally denatured fibrinogen. The fibrinogen may be treated with thrombin to produce fibrin, and additional fibrinogen and factor XIII added to produce a cross-linked fibrin coating. The resulting coated surface is stable, anti-thrombotic and resistant to platelet adhesion. Polymeric materials coated in this way are useful in constructing vascular grafts and prosthetic devices, and provide test systems useful in the study of thrombogenesis.

Abstract: A dynamic environmental control system for managing the environment in a super insulated tightly sealed home which has a heat recovery ventilator connected to a forced air heating system for ventilation. The system controls indoor temperature, humidity and fresh air levels as well as temperature gradients using a heat recovery ventilator, heater and an air ventilation fan. The system can initiate operation of the heat recovery ventilator to exchange moist and polluted inside air for drier fresher outside air to control both inside moisture and air pollutant levels. Air exchanges can be initiated by an internal system timer, manually by building occupants or by the system in response to humidity levels inside the home. The system will determine the moisture contents of inside and outside air and will only attempt to exchange air to lower inside humidity levels when the outside air contains less moisture than the inside air.

Abstract: A surface-strengthened composite ceramic material has a ceramic matrix and a refractory phase dispersed at least in and close to the surface of the matrix. The refractory phase includes beta-alumina particles in which larger cations producing a larger molar volume replace sufficient smaller cations in beta-alumina particles in and close to the surface of the composite ceramic material to cause compressive surface stresses which increase the surface strength of the composite ceramic material. The smaller cations are replaced by the larger cations after firing of the composite ceramic material.

Abstract: A process for forming derivatives of organic compounds as a step during their analysis. A macroreticular resin is used as both an adsorbent for the analyte and the derivatizing reagent and also as a catalyst for the derivatization reaction. Subsequent serial elution of the absorbed compounds leads to simple separation of the derivatized analyte from the starting materials. Further, the resin impregnated with derivatizing reagent can be used to combine the extraction and derivatization of the analyte. As macroreticular resins are relatively inexpensive, they result in reduced costs compared with conventional catalysts, and their ease of separation from liquid systems makes them easy to use and makes it possible to automate the procedure.